First Time Loading...

Pharma Mar SA
OTC:PHMMF

Watchlist Manager
Pharma Mar SA Logo
Pharma Mar SA
OTC:PHMMF
Watchlist
Price: 31.15 USD 16.01% Market Closed
Updated: May 6, 2024

Wall Street
Price Targets

PHMMF Price Targets Summary
Pharma Mar SA

Wall Street analysts forecast PHMMF stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PHMMF is 51.79 USD with a low forecast of 29.32 USD and a high forecast of 72.09 USD.

Lowest
Price Target
29.32 USD
6% Downside
Average
Price Target
51.79 USD
66% Upside
Highest
Price Target
72.09 USD
131% Upside
Pharma Mar SA Competitors:
Price Targets
PRLD
Prelude Therapeutics Inc
53% Upside
TNGX
Tango Therapeutics Inc
136% Upside
PROB
Probi AB
52% Upside
CYTH
Cyclo Therapeutics Inc
123% Upside
7774
Japan Tissue Engineering Co Ltd
92% Upside
3164
GenMont Biotech Inc
347% Upside
298380
ABL Bio Inc
44% Upside
INBX
Inhibrx Inc
6% Upside

Revenue
Forecast

Revenue Estimate
Pharma Mar SA

For the last 8 years the compound annual growth rate for Pharma Mar SA's revenue is -3%. The projected CAGR for the next 3 years is 3%.

-3%
Past Growth
3%
Estimated Growth
Estimates Accuracy
4%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Pharma Mar SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Net Income
Forecast

Net Income Estimate
Pharma Mar SA

For the last 8 years the compound annual growth rate for Pharma Mar SA's net income is -20%. The projected CAGR for the next 3 years is 214%.

-20%
Past Growth
214%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PHMMF's stock price target?
Price Target
51.79 USD

According to Wall Street analysts, the average 1-year price target for PHMMF is 51.79 USD with a low forecast of 29.32 USD and a high forecast of 72.09 USD.

What is Pharma Mar SA's Revenue forecast?
Projected CAGR
3%

For the last 8 years the compound annual growth rate for Pharma Mar SA's revenue is -3%. The projected CAGR for the next 3 years is 3%.

What is Pharma Mar SA's Net Income forecast?
Projected CAGR
214%

For the last 8 years the compound annual growth rate for Pharma Mar SA's net income is -20%. The projected CAGR for the next 3 years is 214%.